ストックスクリーナーアプリを入手
1.12
3.45%
-0.04
アフターアワーズ：
1.14
0.02
+1.79%
Immuron Limited Adr (IMRN) 最新ニュース
Which stocks have an unusual volume on Thursday? - ChartMill
Immuron (NASDAQ: IMRN) responds to ASX query on share price - Stock Titan
Wondering what's happening in today's after-hours session? - ChartMill
Immuron (IMRN) CCO reports 1.14M shares and 640K performance rights in Form 3 - Stock Titan
Number of shareholders of Immuron Limited Sponsored ADR – LSX:A2DTD8 - TradingView
Immuron (NASDAQ: IMRN) details TD portfolio growth and partnering push - Stock Titan
Immuron (IMRN) chairman discloses 1.67M share options - Stock Titan
Immuron (NASDAQ: IMRN) CEO schedules Emerging Growth Conference presentation - Stock Titan
IMRN - Finviz
Unusual VolumeStock ScreenerNews - Finviz
IMRN Stock Price, Quote & Chart | IMMURON LTD-SPON ADR (NASDAQ:IMRN) - ChartMill
Immuron Double Digit 3Q Sales Growth - Sahm
Top 10 at 11: Wall Street hits all-time highs but ASX opens lower as banks retreat - MSN
Immuron (NASDAQ: IMRN) lifts Travelan sales with strong Canada Q3 surge - Stock Titan
Immuron (NASDAQ: IMRN) offers cost-free sale facility for small shareholdings - Stock Titan
Operating cash flow per share of Immuron Limited Sponsored ADR – GETTEX:ANWA - TradingView
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target - Democrat and Chronicle
IMRN Earnings History & Surprises | EPS & Revenue Results | IMMURON LTD-SPON ADR (NASDAQ:IMRN) - ChartMill
Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference - Sahm
Immuron (NASDAQ: IMRN) boosts cash, pursues partners for IMM-124E and IMM-529 - Stock Titan
Immuron Reports HY26 Results and Strategic Reset - GlobeNewswire Inc.
Immuron Reports HY26 Results and Strategic Reset - ChartMill
Immuron (NASDAQ: IMRN) gains A$1.12M non-dilutive R&D refund - Stock Titan
Immuron (NASDAQ: IMRN) shareholders back ratification of prior share issues - Stock Titan
Immuron Limited (IMRN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target - progress-index.com
Immuron Reports Continued Sales Growth - Finviz
Does Immuron Limited (Common Stock) (ANWA) stock trade below intrinsic valueJuly 2025 Spike Watch & Smart Investment Allocation Insights - DonanımHaber
Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Benzinga
[6-K] Immuron Ltd Current Report (Foreign Issuer) | IMRN SEC FilingForm 6-K - Stock Titan
Immuron Limited Announces Quotation of New Securities on ASX - The Globe and Mail
Immuron stock tumbles after trial fails to meet primary endpoint By Investing.com - Investing.com Australia
Immuron stock tumbles after trial fails to meet primary endpoint - Investing.com India
These stocks that are showing activity before the opening bell on Wednesday. - ChartMill
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
ANWA Forecast — Price Target — Prediction for 2026 - TradingView — Track All Markets
Immuron Limited (IMRN) Plunges Amidst Management Uncertainty and Bearish Market Sentiment - FinancialContent
Wondering what's happening in today's pre-market session? - ChartMill
Immuron Reports Strong FY2025 Results and Outlines FY2026 Plans - TipRanks
Immuron IMM-529 IND approved by FDA - FinancialContent
Insights: Immuron Ltd (ASX:IMC) - smallcaps.com.au
IMRN furnishes 6-K with ASX updates and Exhibit 99.1 - Stock Titan
Immuron Submits IMM-529 IND to FDA - GlobeNewswire
Immuron (IMRN) Posts 49% FY2025 Revenue Growth on Travelan Sales - Finviz
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):